Current through Register Vol. 46, No. 39, September 25, 2024
(a)
Applicability.
This section applies to developmental centers and facilities
certified by OPWDD, including family care. It does not apply to service
recipients of Clinic Treatment Facilities as defined in Part 679 of this
title.
(b)
Definitions.
The following definitions are applicable to this section
only.
(1)
AFB smears and
cultures. Laboratory tests used to determine the presence or absence
of an active Mycobacterium tuberculosis infection. They are used to help
determine whether tuberculosis (TB) is confined to the lungs (pulmonary) or has
spread to organs outside the lungs (extrapulmonary).
(2)
Active pulmonary
tuberculosis. A contagious disease of the lungs that is confirmed by
culture to be caused by the microorganism Mycobacterium tuberculosis.
(3)
Employee. Someone who
has an employee-employer full, part-time or seasonal relationship with a
service provider, and who receives monetary or other compensation in exchange
for his/her performance of assigned duties.
(4)
Contractor. A party
subject to a contractual arrangement with OPWDD or a service provider, to
perform a service in exchange for financial or other consideration and who will
be reasonably anticipated to have direct contact with service recipients. This
includes independent contractors and parties who are employed by
contractors.
(5)
Possible
tuberculosis infection. Someone demonstrating a significant reaction
to a TB test, but who has no signs or symptoms of active pulmonary tuberculosis
and no tuberculosis organisms are found in the sputum.
(6)
Mycobacterium tuberculosis (M.
tuberculosis). The bacterium that causes most cases of
tuberculosis.
(7)
Purified
protein derivative (PPD). A purified protein derivative of the
tubercle bacilli, used in the tuberculin skin test (see tuberculin skin
test).
(8)
Service
provider. A developmental center or operator of a facility certified
by OPWDD, other than Clinic Treatment Facilities described in Part 679 of this
title. In the case of a family care home, the sponsoring agency shall be
responsible for complying with requirements applicable to the service
provider.
(9)
Service
recipient. Any person receiving services from a develop- mental center
or facility certified by OPWDD, except for those receiving services through a
Clinic Treatment Facility described in Part 679 of this title.
(10)
Suspected active pulmonary
tuberculosis. A condition in which a person either exhibits the
clinical signs and symptoms of active pulmonary tuberculosis or has a
significant reaction to the TB test and is awaiting the results of diagnostic
testing.
(11)
TB
testing. Screening for tuberculosis infection utilizing a test
currently approved by the United State Food and Drug Administration (FDA)
and/or recommended by the Centers for Disease Control (CDC) for that
purpose.
(12)
Tuberculin
skin test (TST). A test which involves the introduction of a purified
protein derivative (PPD) of the tubercle bacilli, called tuberculin, into the
skin by intradermal injection and which is read in millimeters of induration
within 48-72 hours.
(13)
Two-step PPD. A procedure performed to rule out the presence
of an anamnestic response in people who were infected with tuberculosis in the
distant past. An anamnestic phenomenon is one in which an initial negative TST
triggers an immune response, resulting in a subsequent positive TST.
(14)
Volunteer. A person who
meets the definition of "volunteer" in section
633.99 of
this Part who has regular direct contact with persons receiving services. This
does not include participants in groups that only periodically are in contact
with persons receiving services (e.g., groups who come in to
sing holiday songs). The provisions applying to volunteers in this section also
apply to students, interns and senior companions.
(c)
Testing for TB.
(1) Initial testing.
(i) All employees, volunteers, contractors,
family care providers and approved substitute/respite providers shall have TB
testing completed prior to their first day of employment or service provision.
If using the two-step PPD, individuals may begin work if the first TST is
negative.
(ii) All service
recipients shall either provide proof of TB testing within the last 12 months
or be assessed for signs and symptoms of active pulmonary tuberculosis on or
prior to their first day of receipt of service. TB testing must be carried out
within seven days of the first day of receipt of service.
(iii) An employee, contractor, volunteer,
family care provider, approved substitute/respite provider or service recipient
may select testing by his/her health care provider. The results of the TB
testing and any necessary follow-up evaluation must be documented and shared
with the service provider or sponsoring agency prior to or on the first day of
employment or service provision or receipt of services.
(2) Annual testing - developmental centers
only.
(i) TB testing shall be conducted on an
annual basis for employees, volunteers, contractors, and service recipients who
provide/receive services in a developmental center.
(ii) All service recipients, employees,
volunteers, and contractors who provide/receive services in a developmental
center shall receive annual TB testing within 12 months of their last
documented test. An employee, contractor, volunteer or service recipient may
select testing by his/her own health care provider. The results of the TB
testing and any necessary follow-up evaluation must be documented and shared
with the service provider.
(3)
Exposure testing.
Testing shall be conducted for all service recipients, employees, contractors,
volunteers, family care providers and approved respite/substitute providers who
are exposed to someone with a suspected or confirmed case of active pulmonary
tuberculosis. Such exposure testing will be conducted in cooperation with the
state and local health departments.
(d)
Exclusions/contraindications for TB
testing.
(1) In order for the service
provider to permit a party's exclusion from either
pre-employment/pre-receipt/pre-delivery of services or follow-up TST, the
service provider shall have documentation of one of the following reasons for
contraindication:
(i) prior documented
significant reaction to TB testing; or
(ii) adequate treatment for active pulmonary
tuberculosis; or
(iii) completion
of adequate preventive therapy.
(2) A statement by a physician, nurse
practitioner or physician's assistant of contraindication shall be acceptable
as long as the statement includes:
(i) a
recommendation as to when and if testing would be appropriate at a designated
point in the future; and
(ii) how
the party will be evaluated for active pulmonary tuberculosis in the
interim.
(3) Evaluation
of parties excluded from TB testing. A registered nurse shall conduct a general
evaluation of the party taking into account any present symptomatology and
history since the party's previous TB test or evaluation. Based on such
evaluation the nurse may refer the party to a physician, nurse practitioner or
physician's assistant for a formal diagnostic evaluation to exclude active
pulmonary tuberculosis. Routine chest x-ray examinations are not
required.
(4) Prior vaccination
with Bacillus of Calmette and Guerin (BCG) is not a contraindication for TB
testing. Results are interpreted in the same manner as for someone who has not
been immunized.
(5) Evaluation of a
party excluded from TST testing who has been exposed to someone with a
suspected or confirmed case of active pulmonary tuberculosis. Such party shall
be referred to the local health department for appropriate post-exposure
evaluation.
(e)
Performance and interpretation of TB testing.
(1) TB testing shall be performed in
accordance with generally accepted community practice in the fields of medicine
and nursing.
(2) If an initial TST
is performed, it shall be conducted employing a two-step PPD unless the person
has documented evidence of a TST within the last 12 months.
(3) If a TST is performed, the reading of the
TST shall be performed between 48 and 72 hours after implantation by one of the
following: physician, physician's assistant, nurse practitioner, registered
nurse, or licensed practical nurse. Interpretation of the TST may only be done
by a physician, physician's assistant, nurse practitioner or registered
nurse.
(4) TB test results shall be
documented by the service provider. Documentation shall include the date
tested, the testing method used, the results of the test and the interpretation
of the test. If using the TST, documentation shall also include the testing
material used, the site of implantation, the date of reading and the size of
the reaction in induration (not erythema) in millimeters.
(f)
Evaluation of those with
significant reaction.
Any party with a significant reaction and/or a test result
interpreted to indicate possible tuberculosis infection shall be immediately
referred to a health care provider knowledgeable in the diagnosis of
tuberculosis for a formal diagnostic evaluation to exclude active pulmonary
tuberculosis.
(1) The following
requirements apply to employees, volunteers, contractors, family care providers
and approved substitute/respite providers:
(i)
If initial testing shows a significant reaction and/or a test result
interpreted to indicate possible tuberculosis infection, the party shall not be
allowed to begin employment/service provision until:
(a) the party is evaluated by a health care
provider and found to be free of active pulmonary tuberculosis; or
(b) the party meets the following criteria:
(1) adequate treatment is instituted;
and
(2) the cough is resolved;
and
(3) sputum specimens are
negative on three consecutive AFB smears.
(ii) If annual testing and/or exposure
testing shows a significant reaction and/or a test result interpreted to
indicate possible tuberculosis infection, the party shall be assessed by a
registered nurse, physician, physician's assistant or nurse practitioner for
signs/symptoms of active pulmonary tuberculosis.
(a) Employees, volunteers, and contractors
without signs/symptoms of active pulmonary tuberculosis may continue to work
but must be evaluated within five days. If the evaluation is not completed
within five days, the party will not be allowed to work or provide services
until such evaluation is complete and s/he has met the criteria specified in
subparagraph (1)(i) of this subdivision.
(b) Employees, volunteers, and contractors
with signs/symptoms of active pulmonary tuberculosis shall be immediately
excluded from working or providing services. Such party shall not be allowed to
work or provide services until they have met the criteria specified in
subparagraph (1)(i) of this subdivision.
(c) Family care providers and/or approved
substitute/respite providers without signs/symptoms of active pulmonary
tuberculosis must be evaluated within five days. If the evaluation is not
completed within five days, recipients of service shall be removed from the
home (or the substitute/respite provider shall not be allowed to provide
services elsewhere as appropriate) until such evaluation is complete and s/he
has met the criteria specified in subparagraph (1)(i) of this
subdivision.
(d) Family care
providers and/or approved substitute/respite providers with signs/symptoms of
active pulmonary tuberculosis. Recipients of service shall be immediately
removed from the home, and shall not return to the home (or the
substitute/respite provider shall not be allowed to provide services as
appropriate) until the provider has met the criteria specified in subparagraph
(1)(i) of this subdivision.
(2) The following requirements apply to
service recipients. Any recipient of service who has a significant reaction
and/or a test result interpreted to indicate possible tuberculosis infection
shall be immediately assessed by a registered nurse, physician, physician's
assistant or nurse practitioner for signs/symptoms of active pulmonary
tuberculosis.
(i) Recipients of service
without signs/symptoms of active pulmonary tuberculosis may continue with
his/her normal activities including day program and must be evaluated within
five days. If the evaluation is not completed within five days, the person
shall be confined to his/her room, to the extent possible, until such
evaluation is complete and s/he has met the criteria specified in subparagraph
(1)(i) of this subdivision.
(ii)
Recipients of service with signs/symptoms of active pulmonary tuberculosis are
to be immediately transported to the nearest acute care facility
(e.g., emergency room, urgent care center, etc.) for
evaluation and treatment.
(3) The service provider shall have
documentation by a physician or other health care provider that the criteria
specified in subparagraph (1)(i) of this subdivision have been met before the
service recipient is allowed to return to the developmental center, facility or
family care home or to receive services from a respite/substitute provider, or
the party is allowed to return to work or service provision.
(g)
Maintaining
compliance.
TB testing or evaluation for active tuberculosis shall be
mandatory.
(1) Refusal by an employee,
volunteer or contractor to be tested or evaluated for active pulmonary
tuberculosis shall be considered incompatible with initial or further
employment or affiliation with the service provider or OPWDD.
(2) Refusal by a family care provider or
approved substitute/respite provider to be tested or evaluated for active
pulmonary tuberculosis shall be considered incompatible with the initial and/or
continued certification of the family care home or the approval of the
substitute/respite provider. (This provision does not apply to those family
care providers or approved substitute/respite providers who are making a good
faith effort to comply with testing requirements.)
(3) Refusal by a service recipient to be
tested or evaluated for active pulmonary tuberculosis shall be considered
incompatible with initial or further receipt of services from a service
provider. (This provision does not include those service recipients who are
making a good faith effort to comply with testing requirements.)
(h)
Cooperation and
coordination with public health authorities.
(1) Each suspected or confirmed case of
active pulmonary tuberculosis shall be reported to the local health department
and to OPWDD within 24 hours.
(2)
The service provider and OPWDD will coordinate efforts related to contact
investigation and testing and care of the affected party with the appropriate
local health department and the New York State Department of Health.
(i)
Tuberculosis control
plan and register.
(1) Each service
provider shall have a tuberculosis control plan which includes provisions for:
(i) training to be conducted initially upon
employment and annually thereafter for employees, family care providers and
approved respite/substitute providers on the signs and symptoms of active
pulmonary tuberculosis, and information on agency-specific policies and
procedures;
(ii) ensuring that
employees, contractors, volunteers, family care providers, approved
substitute/respite providers and service recipients are appropriately tested
and evaluated for active pulmonary tuberculosis; and
(iii) maintaining documentation of
testing.
(2) The service
provider shall document all suspected or confirmed cases of active pulmonary
tuberculosis, including maintenance of a register of:
(i) all known or suspected tuberculosis
cases, including the results of tests, x-rays, and treatments carried out and
reports of suspected or confirmed active pulmonary tuberculosis made to the
local health department; and
(ii)
the results of tuberculosis testing noting positive reactions and parties who
have received or are receiving preventive therapy or treatment for active
pulmonary tuberculosis.
(3) A summary of total TB test results shall
be maintained at a location designated by each service provider for employees,
volunteers, contractors, family care providers, approved substitute/respite
providers, and service recipients.